Platelet antiheparin activity. The isolation and characterisation of platelet factor 4 released from thrombin-aggregated washed human platelets and its dissociation into subunits and the isolation of membrane-bound antiheparin activity
- PMID: 1122293
Platelet antiheparin activity. The isolation and characterisation of platelet factor 4 released from thrombin-aggregated washed human platelets and its dissociation into subunits and the isolation of membrane-bound antiheparin activity
Abstract
Platelet factor 4 was isolated by gel filtration from the soluble release products of thrombin-aggregated washed human platelets as a proteoglycan-platelet factor 4 complex of molecular weight 358 000, Stokes radius (r-s) of 14.0 nm, sedimentation coefficient (s) of 7.1 S and frictional ratio (f/f-o) of 3.04. The complex was dissociated at high ionic strength (I equals 0.75) and the proteoglycan separated from platelet factor 4 by gel filtration. Platelet factor 4 had a molecular weight of 27 100, r-s of 2.52 nm, s of 2.4 S and f/f-o of 1.26, was insoluble under physiological conditions but readily soluble at pH 3. Under these conditions platelet factor 4 dissociated into four subunits with a molecular weight of 6900, r-s of 1.92 nm, s of 0.8 S, and f/f-o of 1.52. Qualitative N-terminal amino acid analysis showed the presence of glutamic acid or glutamine as the major end group. Platelet factor 4 was compared with protamine sulphate, which has similar biological properties, by electrophoresis at pH 2.2, in which both migrated as single bands but with differing mobility, and by amino acid analysis which showed a more normal distribution of residues than occurred in protamine sulphate. Of the basic amino acids platelet factor 4 (molecular weight 27 100) contained 5.97% arginine, 3.18% histidine, and 12.31% lysine compared to protamine sulphate with 64.2% arginine, 0.6% lysine and no histidine. A partial specific volume (v) of 0.747 was calculated for platelet factor 4 from its amino acid analysis. A membrane fraction with antiheparin activity, an isopycnic density of 1.090-1.110 and r-s of 15-35 nm, was also isolated by sucrose density gradient centrifugation from the ultrasonicated insoluble platelet residue remaining after thrombin-induced aggregation of washed human platelets. Trypsin treatment of the membrane fraction neither solubilised nor destroyed the activity.
Similar articles
-
The isolation and characterisation of a platelet-specific beta-globulin (beta-thromboglobulin) and the detection of antiurokinase and antiplasmin released from thrombin-aggregated washed human platelets.Biochim Biophys Acta. 1975 Feb 27;379(2):360-9. doi: 10.1016/0005-2795(75)90143-9. Biochim Biophys Acta. 1975. PMID: 47244
-
Antigenic and antiheparin properties of human platelet factor 4 (PF4).Blood. 1975 Apr;45(4):537-50. Blood. 1975. PMID: 803847
-
Platelet antiplasmin: its extrusion during the release reaction, subcellular localization, characterization, and relationship to antiheparin in pig platelets.J Lab Clin Med. 1976 Apr;87(4):659-69. J Lab Clin Med. 1976. PMID: 131845
-
Identification of membrane proteins mediating the interaction of human platelets.J Cell Biol. 1980 Jul;86(1):77-86. doi: 10.1083/jcb.86.1.77. J Cell Biol. 1980. PMID: 6893455 Free PMC article.
-
Platelet heparin-neutralizing factor (platelet factor 4).Thromb Diath Haemorrh. 1975 Feb 28;33(1):66-72. Thromb Diath Haemorrh. 1975. PMID: 1091019 Review.
Cited by
-
Comparative studies of the interaction of human and bovine platelet factor 4 with heparin using histidine NMR resonances as spectroscopic probes.J Protein Chem. 1993 Jun;12(3):303-9. doi: 10.1007/BF01028192. J Protein Chem. 1993. PMID: 8397788
-
COVID-19 vaccine-induced immune thrombotic thrombocytopenia: pathophysiology and diagnosis.Ann Hematol. 2025 Jan;104(1):47-55. doi: 10.1007/s00277-023-05563-1. Epub 2023 Nov 30. Ann Hematol. 2025. PMID: 38030893 Review.
-
Binding of platelet factor 4 to heparin oligosaccharides.Biochem J. 1983 Feb 1;209(2):455-60. doi: 10.1042/bj2090455. Biochem J. 1983. PMID: 6847629 Free PMC article.
-
Effect of felodipine, a new calcium channel antagonist, on platelet function and fibrinolytic activity at rest and after exercise.Eur J Clin Pharmacol. 1989;37(5):453-7. doi: 10.1007/BF00558123. Eur J Clin Pharmacol. 1989. PMID: 2532135
-
Vaccine-induced immune thrombotic thrombocytopenia: Updates in pathobiology and diagnosis.Front Cardiovasc Med. 2022 Oct 24;9:1040196. doi: 10.3389/fcvm.2022.1040196. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36352844 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources